<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04343417</url>
  </required_header>
  <id_info>
    <org_study_id>2000027890</org_study_id>
    <secondary_id>1K23DK117065-01A1</secondary_id>
    <nct_id>NCT04343417</nct_id>
  </id_info>
  <brief_title>Biorepository to Support Research in Kidney Diseases</brief_title>
  <official_title>Biorepository to Support Research in Kidney Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To support advances in the understanding of pathophysiology and therapies of kidney diseases&#xD;
      by creating a BioBank of kidney tissue, DNA, plasma, and urine from patients with kidney&#xD;
      diseases.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A biorepository of human samples to support research to advance understanding of human kidney&#xD;
      diseases will be created. Clinically, kidney diseases are detected by blood and urine&#xD;
      laboratory tests. However, the underlying cause of kidney disease is often not clear on blood&#xD;
      and urine tests. In such cases, a clinician may choose to perform a kidney biopsy to&#xD;
      establish the diagnosis. Patients who are scheduled to undergo a kidney biopsy will be&#xD;
      invited to participate in this proposed study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 28, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2035</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Histological diagnosis</measure>
    <time_frame>5 years</time_frame>
    <description>Histological diagnosis of kidney disease determined by evaluation by renal pathologists</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence of chronic kidney disease, end stage kidney disease or death</measure>
    <time_frame>10 years</time_frame>
    <description>Track outcomes in participants recruited for up to 10 years</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Acute Kidney Injury</condition>
  <condition>Acute Interstitial Nephritis</condition>
  <condition>Kidney Diseases</condition>
  <arm_group>
    <arm_group_label>Biorepository</arm_group_label>
    <description>Participants who contributed biospecimen samples (kidney tissue, blood, urine, DNA).</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood (serum, plasma, and DNA extraction), urine samples, kidney tissue sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The biorepository is a prospective cohort study of subjects with kidney diseases, who are&#xD;
        scheduled to undergo a kidney biopsy at Yale New Haven Hospital (York St. or St. Raphael's&#xD;
        campus) as part of the routine clinical care and agree to participate in this study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients scheduled to undergo a clinically indicated kidney biopsy&#xD;
&#xD;
          -  English speaking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Under 18 years or age&#xD;
&#xD;
          -  Known pregnancy&#xD;
&#xD;
          -  Additional vulnerable individuals (incarcerated, institutionalized, or otherwise&#xD;
             unable to participate in the study)&#xD;
&#xD;
          -  Inability to provide informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Dennis G Moledina, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dennis G Moledina, MD</last_name>
    <phone>2037372782</phone>
    <email>dennis.moledina@yale.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Melissa M Shaw, BS</last_name>
    <phone>2039152211</phone>
    <email>melissa.m.shaw@yale.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Yale New Haven Hospital, York Street Campus</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa M. Shaw, BS</last_name>
    </contact>
    <investigator>
      <last_name>Dennis Moledina, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale New Haven Hospital Saint Raphael Campus</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06511</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>April 8, 2020</study_first_submitted>
  <study_first_submitted_qc>April 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2020</study_first_posted>
  <last_update_submitted>November 18, 2020</last_update_submitted>
  <last_update_submitted_qc>November 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Kidney</keyword>
  <keyword>Kidney Disease</keyword>
  <keyword>Acute Kidney Injury</keyword>
  <keyword>Kidney biopsy</keyword>
  <keyword>Kidney Biorepository</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Nephritis</mesh_term>
    <mesh_term>Nephritis, Interstitial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

